Temasek Holdings to invest Rs 945 crore in Glenmark Pharma

20 Apr 2015 Evaluate

Temasek Holdings, the investment arm of the Singapore government is all set to invest Rs 945 crore in Glenmark Pharmaceuticals. The move will help ease Glenmark’s debt burden of $420 million.

Temasek Holdings was considering investing in it through its wholly-owned subsidiary Aranda Investments (Mauritius), in equity shares to be issued by the company on a preferential basis.

Last year, Glenmark’s board had approved a proposal to merge Glenmark Pharmaceuticals’ subsidiaries - Glenmark Generics (GGL) and Glenmark Access (GAL) - with the parent company.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×